Literature DB >> 16651618

Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis.

Karin List1, Roman Szabo, Alfredo Molinolo, Boye Schnack Nielsen, Thomas H Bugge.   

Abstract

The membrane serine protease matriptase is required for epidermal barrier function, hair formation, and thymocyte development in mice, and dysregulated matriptase expression causes epidermal squamous cell carcinoma. To elucidate the specific functions of matriptase in normal and aberrant epidermal differentiation, we used enzymatic gene trapping combined with immunohistochemical, ultrastructural, and barrier function assays to delineate the spatio-temporal expression and function of matriptase in mouse keratinized tissue development, homeostasis, and malignant transformation. In the interfollicular epidermis, matriptase expression was restricted to postmitotic transitional layer keratinocytes undergoing terminal differentiation. Matriptase was also expressed in keratinizing oral epithelium, where it was required for oral barrier function, and in thymic epithelium. In all three tissues, matriptase colocalized with profilaggrin. In staged embryos, the onset of epidermal matriptase expression coincided with that of profilaggrin expression and acquisition of the epidermal barrier. In marked contrast to stratifying keritinized epithelium, matripase expression commenced already in undifferentiated and rapidly proliferating profilaggrin-negative matrix cells and displayed hair growth cycle-dependent expression. Exposure of the epidermis to carcinogens led to the gradual appearance of matriptase in a keratin-5-positive proliferative cell compartment during malignant progression. Combined with previous studies, these data suggest that matriptase has diverging functions in the genesis of stratified keratinized epithelium, hair follicles, and squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651618      PMCID: PMC1606590          DOI: 10.2353/ajpath.2006.051071

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity.

Authors:  C Y Lin; J Anders; M Johnson; Q A Sang; R B Dickson
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis.

Authors:  M Simon; M Haftek; M Sebbag; M Montézin; E Girbal-Neuhauser; D Schmitt; G Serre
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.

Authors:  Pascal Descargues; Céline Deraison; Chrystelle Bonnart; Maaike Kreft; Mari Kishibe; Akemi Ishida-Yamamoto; Peter Elias; Yann Barrandon; Giovanna Zambruno; Arnoud Sonnenberg; Alain Hovnanian
Journal:  Nat Genet       Date:  2004-12-26       Impact factor: 38.330

4.  The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope.

Authors:  P M Steinert; L N Marekov
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

5.  Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome.

Authors:  Duncan R Hewett; Alison L Simons; Niamh E Mangan; Helen E Jolin; Shelia M Green; Padraic G Fallon; Andrew N J McKenzie
Journal:  Hum Mol Genet       Date:  2004-12-08       Impact factor: 6.150

6.  A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis.

Authors:  R Paus; S Müller-Röver; C Van Der Veen; M Maurer; S Eichmüller; G Ling; U Hofmann; K Foitzik; L Mecklenburg; B Handjiski
Journal:  J Invest Dermatol       Date:  1999-10       Impact factor: 8.551

7.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.

Authors:  T Takeuchi; M A Shuman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 8.  Cellular and molecular basis of barrier function in oral epithelium.

Authors:  P W Wertz; C A Squier
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1991       Impact factor: 4.889

Review 9.  The cornified envelope: a model of cell death in the skin.

Authors:  Eleonora Candi; Rainer Schmidt; Gerry Melino
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

10.  Patterned acquisition of skin barrier function during development.

Authors:  M J Hardman; P Sisi; D N Banbury; C Byrne
Journal:  Development       Date:  1998-04       Impact factor: 6.868

View more
  44 in total

1.  Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation.

Authors:  Jung-Da Fang; Hsiao-Chin Chou; Hsiu-Hui Tung; Pao-Yi Huang; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

3.  Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Authors:  Roman Szabo; John P Hobson; Karin List; Alfredo Molinolo; Chen-Yong Lin; Thomas H Bugge
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

4.  Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase.

Authors:  Lina Basel-Vanagaite; Revital Attia; Akemi Ishida-Yamamoto; Limor Rainshtein; Dan Ben Amitai; Raziel Lurie; Metsada Pasmanik-Chor; Margarita Indelman; Alex Zvulunov; Shirley Saban; Nurit Magal; Eli Sprecher; Mordechai Shohat
Journal:  Am J Hum Genet       Date:  2007-01-23       Impact factor: 11.025

Review 5.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

6.  Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.

Authors:  Kuniyo Inouye; Marie Tomoishi; Makoto Yasumoto; Yuka Miyake; Kenji Kojima; Satoshi Tsuzuki; Tohru Fushiki
Journal:  J Biochem       Date:  2012-10-03       Impact factor: 3.387

7.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

8.  Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.

Authors:  Marguerite S Buzza; Erik W Martin; Kathryn H Driesbaugh; Antoine Désilets; Richard Leduc; Toni M Antalis
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

9.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

10.  Disruption of epidermal specific gene expression and delayed skin development in AP-2 gamma mutant mice.

Authors:  Jillian Guttormsen; Maranke I Koster; John R Stevens; Dennis R Roop; Trevor Williams; Quinton A Winger
Journal:  Dev Biol       Date:  2008-02-21       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.